The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).

MLA

Taucher, Susanne, et al. “The Potential Risk of Neoadjuvant Chemotherapy in Breast Cancer Patients--Results from a Prospective Randomized Trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).” Breast Cancer Research and Treatment, vol. 112, no. 2, Nov. 2008, pp. 309–16. EBSCOhost, https://doi.org/10.1007/s10549-007-9844-9.

APA

Taucher, S., Steger, G. G., Jakesz, R., Tausch, C., Wette, V., Schippinger, W., Kwasny, W., Reiner, G., Greil, R., Dubsky, P., Poestlberger, S., Tschmelitsch, J., Samonigg, H., & Gnant, M. (2008). The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07). Breast Cancer Research and Treatment, 112(2), 309–316. https://doi.org/10.1007/s10549-007-9844-9

Chicago

Taucher, Susanne, Guenther G Steger, Raimund Jakesz, Christoph Tausch, Viktor Wette, Walter Schippinger, Werner Kwasny, et al. 2008. “The Potential Risk of Neoadjuvant Chemotherapy in Breast Cancer Patients--Results from a Prospective Randomized Trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).” Breast Cancer Research and Treatment 112 (2): 309–16. doi:10.1007/s10549-007-9844-9.